Endlyz Therapeutics, Inc.
Form D Filings
Location
Boston, MA
Industry Group
Biotechnology
Related People
Zaven Kaprielian
,
Jonathan Behr
,
John Gustofson
,
Damian Crowther
,
Joanna Wolak
Entity Type
Corporation
CIK
0001875514
All SEC Filings
View on sec.gov
Date Filed
Security Types
Total Amount Sold
Total Offering
Amount Remaining
First Sale
Signed
Form
SEC Link
7/29/2021
Equity
$3,250,000
$6,500,000
$3,250,000
7/16/2021
7/29/2021
D
000187551421000001